Interaction of small molecules with specific immune receptors: the p-i concept and its consequences

Pichler, Werner Joseph; Watkins, Stephan Lloyd (2014). Interaction of small molecules with specific immune receptors: the p-i concept and its consequences. Current Immunology Reviews, 10(1), pp. 7-18. Bentham Science Publishers

[img] Text
art00004.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB) | Request a copy

Drugs may stimulate the immune system by forming stable new antigenic complexes consisting of the drug or drug metabolite which is covalently bound to a protein or peptide (hapten-carrier complex). Both, B- and T-cell immunity may arise, the latter directed to hapten modified peptides presented by HLA molecules. Beside this immunological stimulation, drugs can also stimulate the immune system through binding by non-covalent bonds to proteins like immune receptors. This so-called “pharmacological interaction with immune receptors” concept (“p-i concept”) may occur with HLA or TCR molecules themselves (p-i HLA or p-i TCR), and not the immunogenic peptide. It is a type of “off-target” activity of the drug on immune receptors, but more complex as various cell types, cell interactions and functionally different T cells are involved. In this review the conditions which lead to activation of T cells by p-i are discussed: important factors for a functional consequence of drug binding is the location of binding (p-i HLA or p-i TCR); the exact site within these immune receptors; the affinity of binding and the finding that p-i HLA can stimulate the immune system like an allo-allele. The p-i concept is able to solve some puzzles of drug hypersensitivity reactions and are a basis to better treat and potentially avoid drug hypersensitivity reactions. Moreover, the p-i concept shows that in contrast to previous beliefs small molecules do interact with immune receptors with functional consequence. But these interactions are not based on “immune recognition”, are at odds with some immunological concepts, but may nevertheless open new possibilities to understand and even treat immune reactions

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology

UniBE Contributor:

Pichler, Werner Joseph and Watkins, Stephan Lloyd

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1573-3955

Publisher:

Bentham Science Publishers

Language:

English

Submitter:

Stefan Kuchen

Date Deposited:

07 Apr 2015 11:30

Last Modified:

06 Nov 2015 09:19

BORIS DOI:

10.7892/boris.66145

URI:

https://boris.unibe.ch/id/eprint/66145

Actions (login required)

Edit item Edit item
Provide Feedback